Navina Deepens Value-Based Care Focus With New Advisor, Regulatory-Aligned AI Push, and Expanded ACO Engagement

Navina – an AI-driven clinical decision support and workflow platform – saw a week of activity centered on executive bench strength, regulatory tailwinds, and deeper engagement with value-based care stakeholders. The company added former Humana CEO Bruce Broussard to its advisory board, aiming to leverage his three decades of experience in value-based care, payer-provider integration, and scaling data-driven healthcare models.

Navina continues to promote its “clinically grounded, agentic AI” platform designed to bring real-time clinical intelligence into providers’ workflows and support more proactive, coordinated care. More than 20,000 clinicians and care team members reportedly use the platform in real patient care, covering over 3 million patients and highlighting growing adoption across health systems and risk-bearing entities.

The company emphasized regulatory-driven demand for prospective risk adjustment, citing CMS plans to prioritize encounter-based documentation by 2027 and intensifying RADV audits. Through an upcoming webinar with industry group RISE, Navina is positioning its technology and services as tools to help payers and providers move risk capture upstream and manage compliance and audit exposure more effectively.

Navina also targeted REACH ACOs weighing participation in the LEAD model, which offers longer-term benchmark stability and full two-sided risk but requires strong operational and clinical performance. A decision guide developed with experts Kim Lynch and Dr. Mark McClellan is intended to help ACOs compare LEAD Global, LEAD Professional, and MSSP Enhanced options and align model selection with risk tolerance and infrastructure readiness.

Conference activity remained robust, with Navina engaging ACO and value-based care leaders at NAACOS 2026 and AMGA’s annual meeting. The company offered MSSP reports, strategy sessions, and workshops on embedding AI into clinical workflows, using these forums to showcase its capabilities, address workflow fragmentation, and deepen relationships with top-performing organizations.

Navina also highlighted repeat industry recognition, having received a Gold Stevie Award for AI in Healthcare for the second consecutive year, reinforcing its credibility in the healthcare AI segment. The company is further elevating its thought leadership through Navina Ascend, a planned executive event featuring leaders from Mosaic, Kaiser Permanente, Summit Health, and Summit Medical Group to discuss AI, value-based care, and operational innovation.

Collectively, these developments suggest Navina is sharpening its focus on regulatory-aligned solutions, strategic advisory offerings, and high-level ecosystem engagement. While advisory appointments and conferences do not guarantee specific financial outcomes, the combination of reported adoption, awards, and targeted outreach appears supportive of the company’s longer-term positioning in value-based care and AI-enabled clinical decision support.